CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal
Percentage of 122 non-HDMTX and 24 HDMTX patients with total CNS-IPI... | Download Scientific Diagram
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients
PDF] Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. | Semantic Scholar
1876-CNS prophylaxis in diffuse large B cell lymphoma | eviQ
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu
British Journal of Haematology | Wiley Online Library
Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review - ScienceDirect
Lymphoma IPI Score Calculator - Apps on Google Play
Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients
Baseline patient characteristics by CNS-IPI score | Download Table
CNS-IPI in the study population | Download Table
PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
Application of the Central Nervous System International Prognostic Index ( CNS-IPI) score in daily practice: a retrospective analysis apart from the clinical trial at two centers in Brazil - ScienceDirect
1876-CNS prophylaxis in diffuse large B cell lymphoma | eviQ
Comparison of classic IPI, NCCN-IPI, and modified prognostic model for... | Download Table
Cancers | Free Full-Text | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL - ScienceDirect
CDHB Red Book
Frontiers | A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma | Oncohema Key
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Full article: Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study